$1.04
-0.0073-0.7%
Últ. Act.: Oct 23, 4:04 PM
ABVC BioPharma (ABVC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | — | — | — | — |
| Actual | $-0.03 | $-0.06 | $-0.16 | $-0.05 |
| Surprise | — | — | — | — |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $795950 |
| Surprise | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 14, 2023 | $-0.68 | $-0.60 | -1333.3 % |
| Q1 | May 15, 2023 | $-0.60 | $-0.50 | -2000.0 % |
| Q4 | Mar 31, 2023 | $-1.50 | $-1.50 | 0.00 % |
| Q3 | Nov 15, 2021 | $-0.70 | $-0.40 | -7500.0 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 14, 2023 | $6.11K | $300.00K | -98.0 % |
| Q1 | May 15, 2023 | $128.27K | $128.00K | 0.21 % |
| Q4 | Mar 31, 2023 | $588.99K | $10.00K | 5789.9 % |
| Q3 | Nov 15, 2021 | $99.00K | $190.00K | -47.9 % |